Nitorum Capital, L.P. Mannkind Corp Transaction History
Nitorum Capital, L.P.
- $547 Million
- Q1 2025
A detailed history of Nitorum Capital, L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 7,785,702 shares of MNKD stock, worth $33.5 Million. This represents 7.16% of its overall portfolio holdings.
Number of Shares
7,785,702
Previous 8,747,316
10.99%
Holding current value
$33.5 Million
Previous $56.2 Million
30.37%
% of portfolio
7.16%
Previous 8.23%
Shares
7 transactions
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$74.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$40.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$37.6 Million0.71% of portfolio
-
Geode Capital Management, LLC Boston, MA6.79MShares$29.2 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.11B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...